SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression
Enhancers shape gene expression patterns and are involved in disease pathogenesis. Here the authors demonstrate a strategy to screen functional regulatory elements for non-coding RNAs ― illustrated with miR-146a ― and link autoimmune disease risk genetic variants to autoimmune disease etiology.
Guardado en:
Autores principales: | Guojun Hou, Isaac T. W. Harley, Xiaoming Lu, Tian Zhou, Ning Xu, Chao Yao, Yuting Qin, Ye Ouyang, Jianyang Ma, Xinyi Zhu, Xiang Yu, Hong Xu, Dai Dai, Huihua Ding, Zhihua Yin, Zhizhong Ye, Jun Deng, Mi Zhou, Yuanjia Tang, Bahram Namjou, Ya Guo, Matthew T. Weirauch, Leah C. Kottyan, John B. Harley, Nan Shen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/de8dfa40a050458585327f2085f7931f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Characterization of the Phosphoproteome in SLE Patients.
por: Xinzhou Zhang, et al.
Publicado: (2012) -
SLE and purine metabolizing ecto-enzymes
por: Bruce N. Cronstein
Publicado: (2021) -
Autoimmune Thrombocytopenia in SLE and COVID-19
por: Yeremia Suryo Pratama, et al.
Publicado: (2021) -
Canadian workplace experiences of systemic lupus erythematosus (SLE)
por: Ann E Clarke, et al.
Publicado: (2021) -
Dysregulated neutrophilic cell death in SLE: a spotlight on ferroptosis
por: Kim Ohl, et al.
Publicado: (2021)